BioCentury
ARTICLE | Finance

Familiarity breeds content

Euronext IPO for LSP fund to invest in publicly listed biotechs

May 2, 2011 7:00 AM UTC

European life sciences firm LSP raised €36 million ($52.5 million) last week in an IPO for its first in-house fund to invest in public companies. The firm is capitalizing on investors' familiarity with its venture performance as well as a return in excess of 150% on the public portfolio it has managed for a pension fund since early 2008.

On Wednesday, LSP Life Sciences Fund (Euronext:LSP) sold 360,000 shares at €100 per share...